keyword
https://read.qxmd.com/read/38541967/evaluation-of-serum-myostatin-concentration-in-chronic-heart-failure-with-preserved-and-impaired-left-ventricular-ejection-fraction
#21
JOURNAL ARTICLE
Jan Bączek, Mirosław Charkiewicz, Agnieszka Kasiukiewicz, Anna Maria Witkowska, Łukasz Magnuszewski, Marta Bączek, Zyta Beata Wojszel
Background: Chronic heart failure (CHF) is a complex clinical syndrome associated with muscle wasting, which can progress to cardiac cachexia. Myostatin, a negative regulator of muscle growth, has been implicated in the pathophysiology of muscle wasting in CHF patients and suggested as a potential biomarker. The objective of this study was to investigate serum myostatin concentration in patients with CHF with preserved and reduced ejection fraction. Methods: The authors conducted a single-centre study comparing serum myostatin levels, functional and echocardiographic parameters, muscle mass, strength and function in patients with CHF to a control group without CHF...
March 18, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38540209/impact-of-pharmacogenetic-testing-on-clozapine-treatment-efficacy-in-patients-with-treatment-resistant-schizophrenia
#22
JOURNAL ARTICLE
Estela Sangüesa, Emilio Fernández-Egea, Julia Concha, Cristina B García, María Pilar Ribate
Managing schizophrenia with clozapine poses a significant challenge due to prevalent therapeutic failures. The increasing interest in personalized medicine underscores the importance of integrating pharmacogenetic information for effective pharmacotherapeutic monitoring in patients. The objective of this study was to explore the correlation between DRD2 , HTR2A , SLC6A4 , CYP1A2 , and ABCB1 polymorphisms and clozapine response in 100 patients with Treatment-Resistant Schizophrenia. Different scales such as the Positive and Negative Syndrome Scale (PANSS), the Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS), the Global Assessment of Functioning Scale (GAF), the Brief Negative Symptom Scale (BNSS), and pharmacokinetic parameters were used to analyse the efficacy of the treatment...
March 7, 2024: Biomedicines
https://read.qxmd.com/read/38537443/yi-qi-huo-xue-decoction-alleviates-intracerebral-hemorrhage-injury-through-inhibiting-neuronal-autophagy-of-ipsilateral-cortex-via-bdnf-trkb-pathway
#23
JOURNAL ARTICLE
Dan Han, Xinyue Chang, Dan Xu, Jizhong Shen, Ali Fan, Meihua Wang, Dingran Li, Xiangkai Chen, Cheng Wang, Yi Wu, Zhaocong Yang, Jian Li, Siliang Wang
BACKGROUND: Yi-Qi-Huo-Xue Decoction (YQHXD), a traditional Chinese medicine formula, has demonstrated efficacy in the clinical treatment of intracerebral hemorrhage (ICH) for over a decade. Nevertheless, the precise pharmacotherapeutic compounds of YQHXD capable of penetrating into cerebral tissue and the pharmacological underpinnings of YQHXD remain ambiguous. METHODS: The active components of YQHXD in rat brains was analyzed by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry...
February 19, 2024: Phytomedicine
https://read.qxmd.com/read/38532786/weak-base-drug-induced-endolysosome-iron-dyshomeostasis-controls-the-generation-of-reactive-oxygen-species-mitochondrial-depolarization-and-cytotoxicity
#24
JOURNAL ARTICLE
Peter W Halcrow, Darius N K Quansah, Nirmal Kumar, Rebecca L Solloway, Kayla M Teigen, Kasumi A Lee, Braelyn Liang, Jonathan D Geiger
OBJECTIVES: Approximately 75 % of marketed drugs have the physicochemical property of being weak bases. Weak-base drugs with relatively high pKa values enter acidic organelles including endosomes and lysosomes (endolysosomes), reside in and de-acidify endolysosomes, and induce cytotoxicity. Divalent cations within endolysosomes, including iron, are released upon endolysosome de-acidification. Endolysosomes are "master regulators of iron homeostasis", and neurodegeneration is linked to ferrous iron (Fe2+ )-induced reactive oxygen species (ROS) generation via Fenton chemistry...
March 2024: NeuroImmune Pharm Ther
https://read.qxmd.com/read/38532053/personalized-antifungal-therapy-through-model-informed-precision-dosing-of-posaconazole
#25
JOURNAL ARTICLE
Anouk M E Jansen, Kim Snijdelaar, Ron J Keizer, Isabel Spriet, Erwin Dreesen, Roger J M Brüggemann, Rob Ter Heine
BACKGROUND AND OBJECTIVE: Posaconazole is a pharmacotherapeutic pillar for prophylaxis and treatment of invasive fungal diseases. Dose individualization is of utmost importance as achieving adequate antifungal exposure is associated with improved outcome. This study aimed to select and evaluate a model-informed precision dosing strategy for posaconazole. METHODS: Available population pharmacokinetic models for posaconazole administered as a solid oral tablet were extracted from the literature and evaluated using data from a previously published prospective study combined with data collected during routine clinical practice...
March 26, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38528338/pharmacogenomics-in-clinical-practice-for-older-people
#26
JOURNAL ARTICLE
Syeda R Hashimi, Olajumoke Babatunde, Khalifa Alrajeh, Richard J Dixon, Aimalohi Okpeku, Elvin T Price
Older people are over-represented among individuals that experience adverse drug reactions (ADR) and adverse drug events (ADE). Furthermore, older people are over-represented among individuals that visit emergency departments and are hospitalized because of ADRs. Moreover, older people are overrepresented among those who suffer ADEs while hospitalized. Finally, older people are among those most likely to have an anaphylactic response to prescription medications. Therefore, older people are prime candidates for efforts aimed at optimizing pharmacotherapeutic outcomes...
April 1, 2024: Senior Care Pharmacist
https://read.qxmd.com/read/38527979/neurobiological-mechanisms-and-therapeutic-impact-of-electroconvulsive-therapy-ect
#27
JOURNAL ARTICLE
Ana Maria Cojocaru, Antonia Ioana Vasile, Simona Corina Trifu
Electroconvulsive therapy (ECT) is an efficient therapeutic resource for psycho-pharmacotherapeutic resistant forms of depression. ECT is a form of electrical brain stimulation involving the induction of a controlled seizure, clinically similar to an epileptic seizure, that is initiated in the prefrontal region of the brain and spreads to the cortex and subcortex, including the diencephalic structures. This is achieved by creating a transcranial electric field and synchronously depolarizing neuronal membranes...
2024: Romanian Journal of Morphology and Embryology
https://read.qxmd.com/read/38527475/the-epidemiology-transmission-diagnosis-and-management-of-drug-resistant-tuberculosis-lessons-from-the-south-african-experience
#28
REVIEW
Kogieleum Naidoo, Rubeshan Perumal, Helen Cox, Barun Mathema, Marian Loveday, Nazir Ismail, Shaheed Vally Omar, Sophia B Georghiou, Amrita Daftary, Max O'Donnell, Norbert Ndjeka
Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance...
March 22, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38525091/roles-of-pharmacists-in-the-management-of-sickle-cell-disease-in-adults-a-narrative-review
#29
REVIEW
Salome Bwayo Weaver, Nkem P Nonyel, Dhakrit Rungkitwattanakul
Background: Sickle cell disease (SCD) is an autosomal, recessive, genetic condition of the sickle cell genes. It affects about 100 000 people in the United States where an estimated 1 out of every 365 black children and 1 out of every 13 black children will be born with SCD and sickle cell trait, respectively. Severe and unpredictable pain crisis are the leading cause of emergency department visit for adult patients with SCD and account for 90% of inpatient hospitalizations and 85% of all acute medical care, as well as high usage of medical resources...
April 2024: Journal of Pharmacy Technology: JPT: Official Publication of the Association of Pharmacy Technicians
https://read.qxmd.com/read/38524578/novel-insights-into-post-marketing-adverse-events-associated-with-lenvatinib-a-comprehensive-analysis-utilizing-the-faers-database
#30
JOURNAL ARTICLE
Zhe Yu, Jing Luo, Hongshan Wei
PURPOSE: The primary aim of this study was to closely monitor and identify adverse events (AEs) linked to lenvatinib, a pharmacotherapeutic agent employed for the management of renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma. The ultimate goal was to optimize patient safety and provide evidence-based guidance for the appropriate utilization of this medication. METHODS: A comprehensive collection and analysis of reports from the FDA Adverse Event Reporting System (FAERS) database was conducted, encompassing the period from the first quarter of 2015 to the first quarter of 2023...
March 30, 2024: Heliyon
https://read.qxmd.com/read/38512148/-high-lithium-serum-level-as-maintenance-treatment-of-rapid-cycling-bipolar-disorder
#31
REVIEW
F P N Detmers Blom, M de Leeuw
Bipolar disorder with a rapid cycling course can be difficult to treat, often involving therapy resistance. A 55-year old patient with bipolar disorder with rapid cycling course did not stabilize for years, despite various pharmacotherapeutic treatments. Only after lithium was introduced as a maintenance treatment at a level of around 1.20 mmol/l, a long-term stabilization of mood developed which also persisted. A literature review was performed which concluded that maintenance treatment with lithium at levels above 1...
2024: Tijdschrift Voor Psychiatrie
https://read.qxmd.com/read/38511572/essential-oil-and-plant-extract-of-oregano-as-agents-influencing-the-virulence-factors-of-candida-albicans
#32
JOURNAL ARTICLE
P Váczi, M Proškovcová, E Čonková, D Marcinčáková, M Bačkorová, M Harčárová
Candida albicans, a polymorphic yeast, is a physiological component of the human and animal commensal microbiome. It is an etiological factor of candidiasis, which is treated by azole antifungals. Growing resistance to azoles is a reason to look for other alternative treatment options. The pharmacotherapeutic use of plant extracts and essential oils has become increasingly important. In our experiment, C. albicans showed susceptibility to four observed plant extracts and essential oils from peppermint ( Mentha piperita), thyme ( Thymus vulgaris), sage ( Salvia officinalis), and oregano ( Origanum vulgare)...
March 20, 2024: Polish Journal of Veterinary Sciences
https://read.qxmd.com/read/38502672/feasibility-and-utility-of-in-home-body-weight-support-harness-system-use-in-young-children-treated-for-spinal-muscular-atrophy-a-single-arm-prospective-cohort-study
#33
JOURNAL ARTICLE
Megan A Iammarino, Lindsay N Alfano, Natalie F Reash, Brenna Sabo, Sara Conroy, Garey Noritz, Madalynn Wendland, Linda P Lowes
PURPOSE: This single-arm prospective cohort study aimed to evaluate the feasibility and utility of in-home body weight support harness system (BWSS) use in children treated for spinal muscular atrophy (SMA). METHODS: Individuals with 2 or 3 copies of SMN2 who received pharmacotherapeutic treatment, had head control, and weight <50lbs were enrolled. Families were provided a BWSS and documented use. Motor outcome assessments were completed at baseline, month 3 and month 6...
2024: PloS One
https://read.qxmd.com/read/38494132/high-persistence-and-low-treatment-rates-of-metabolic-syndrome-in-patients-with-mood-and-anxiety-disorders-a-naturalistic-follow-up-study
#34
JOURNAL ARTICLE
Jurriaan J M J L Brouwer, Klaas J Wardenaar, Edith J Liemburg, Bennard Doornbos, Hans Mulder, Danielle C Cath
BACKGROUND: Patients with affective and anxiety disorders are at risk of metabolic syndrome (MetS) and, consequently, cardiovascular disease and premature death. In this study, the course and treatment of MetS was investigated using longitudinal data from a naturalistic sample of affective- and anxiety-disordered outpatients (Monitoring Outcome of psychiatric PHARmacotherapy [MOPHAR]). METHODS: Demographics, clinical characteristics, medication use, and MetS components were obtained for n = 2098 patients at baseline and, in a FU-subsample of n = 507 patients, after a median follow-up (FU) of 11 months...
March 15, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38490808/components-from-curcuma-longa-turmeric-against-hepatobiliary-diseases-based-on-gut-liver-axis-pharmacotherapeutic-properties-and-potential-clinical-applications
#35
JOURNAL ARTICLE
Tianhui Gao, Shuyi Wang, Zongping Zhu, Liting Lin, Yirong Luo, Meigui Lu, Wan Liao
Turmeric is widely used worldwide, and there are many examples of its use in treating hepatobiliary diseases. The gut-liver axis is a bidirectional relationship between gut microorganisms and the liver that is closely related to the pathogenesis of hepatobiliary diseases. This review systematically summarizes the components of turmeric. It links the studies on turmeric affecting gut microorganisms to its effects on liver and biliary diseases to explain the potential mechanism of turmeric's regulation of the gut-liver axis...
March 16, 2024: American Journal of Chinese Medicine
https://read.qxmd.com/read/38489072/psoralen-a-narrative-review-of-current-and-future-therapeutic-uses
#36
REVIEW
Panagis Galiatsatos, Daniella D Maydan, Elle Macalpine, Beatrice Schleupner, Alexandra Hunter Aitchison, Andrew D Lerner, Benjamin Levy, Aditya Halthore, William Eward
Psoralen is a family of naturally occurring photoactive compounds found in plants that acquire potential cytotoxicity when activated by specific frequencies of electromagnetic waves. Psoralens penetrate the phospholipid cellular membranes and insert themselves between the pyrimidines of deoxyribonucleic acid (DNA). Psoralens are initially biologically inert and acquire photoreactivity when exposed to certain classes of electromagnetic radiation, such as ultraviolet light. Once activated, psoralens form mono- and di-adducts with DNA, leading to marked cell apoptosis...
March 15, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38488824/pharmacotherapeutic-advances-for-chronic-myelogenous-leukemia-beyond-tyrosine-kinase-inhibitors
#37
REVIEW
Alessandro Costa, Emilia Scalzulli, Ida Carmosino, Claudia Ielo, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia
INTRODUCTION: Despite the notable success of tyrosine kinase inhibitors (TKIs) in treating chronic myeloid leukemia (CML), a subset of patients experiences resistance, or relapse after discontinuation. This challenge is attributed to the Ph+ leukemia stem cells (LSCs) pool not fully involved in the inhibition process due to the current therapeutic approach. AREAS COVERED: Current pharmacological advancements in CML therapy focus on targeting LSCs, intervening in self-renewal pathways, and exploiting biological vulnerabilities...
March 15, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38474723/pharmacological-studies-in-eating-disorders-a-historical-review
#38
REVIEW
Yael D Lewis, Lukas Bergner, Holger Steinberg, Jessica Bentley, Hubertus Himmerich
Eating disorders (EDs) are serious mental health conditions characterised by impaired eating behaviours and nutrition as well as disturbed body image, entailing considerable mortality and morbidity. Psychopharmacological medication is an important component in the treatment of EDs. In this review, we performed a historic analysis of pharmacotherapeutic research in EDs based on the scientific studies included in the recently published World Federation of Societies for Biological Psychiatry (WFSBP) guidelines for ED treatment...
February 22, 2024: Nutrients
https://read.qxmd.com/read/38471973/anti-obesity-medications-current-and-futurean-overview-of-therapeutic-options-of-obesity-management-in-india-the-integrated-diabetes-and-endocrinology-academy-idea-2023-congress-update
#39
REVIEW
Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Om Tantia, Ghanshyam Goyal, Jagat Jyoti Mukherjee, Awadhesh Kumar Singh
INTRODUCTION: With newer anti-obesity medications (AOMs) being introduced at a rapid pace, it is prudent to make a concise and updated clinical practice document that may help busy clinicians in daily clinical practice. A group of metabolic physicians, diabetologists, endocrinologists, and bariatric surgeons assembled during the Integrated Diabetes and Endocrine Academy 2023 Congress (IDEACON, July 2023, Kolkata, India) to compile an update of pharmacotherapeutic options for managing people with obesity in India...
March 12, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38466272/approach-to-obesity-treatment-in-primary-care-a-review
#40
JOURNAL ARTICLE
Susan Z Yanovski, Jack A Yanovski
IMPORTANCE: More than 40% of US adults have obesity, which increases the risks for multiple chronic diseases and premature mortality. Historically, nonsurgical interventions often have not led to sufficient weight loss and maintenance to improve health, but highly effective antiobesity medications (AOMs) have recently become available, and additional effective therapeutics are under development. Given that most medical care for adults with obesity is delivered in primary care settings, guidance for integrating weight-management approaches is needed...
March 11, 2024: JAMA Internal Medicine
keyword
keyword
19274
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.